Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-10 · accession 0000899243-23-018109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-14 | 2023-08-10 | VRTX | Sachdev Amit | EVP, Chief Patient Off | S - Sale | $350.00 | -10.0K | 58.8K | -15% | -$3.51M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-10 | S | D | 10,031 | $350.00 | 58,814 | D | — | — |